You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Vaccine

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Unrecognized Condition Trial in Merkez (Vaccine Education Program Based on Integrated Change Model)

Not yet recruiting
  • Unrecognized Condition
  • Vaccine Education Program Based on Integrated Change Model
  • Merkez, Artvin, Turkey
    Deniz S. Sümeyye YORULMAZ
Jun 30, 2023

Vaccine Response Trial in Atlanta (Atorvastatin, Quadrivalent seasonal influenza vaccine)

Not yet recruiting
  • Vaccine Response
  • Atlanta, Georgia
    Hope Clinic
Aug 29, 2023

SARS-CoV-2 Infection, Varicella, Measles Trial in Shanghai (Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine,

Not yet recruiting
  • SARS-CoV-2 Infection
  • +4 more
  • Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai Municipal Center for Disease Control and Prevention
Jul 17, 2023

Meningococcal Infection (Healthy Volunteers) Trial in Middelburg (Meningococcal Polysaccharide (Serogroups A, C, Y, and W)

Recruiting
  • Meningococcal Infection (Healthy Volunteers)
  • Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine
  • +11 more
  • Middelburg, South Africa
    Investigational Site Number: 7100001
Apr 4, 2023

Vaccine Refusal, Vaccine-Preventable Diseases, Physician-Patient Relations Trial in Royal Oak (Immersive resident education,

Not yet recruiting
  • Vaccine Refusal
  • +2 more
  • Immersive resident education
  • Standardized patient (SP) encounter
  • Royal Oak, Michigan
    Beaumont Health System
Oct 5, 2023

Influenza, Human Trial (sa-mRNA vaccine Dose 1, sa-mRNA vaccine Dose 2, sa-mRNA vaccine Dose 3)

Not yet recruiting
  • Influenza, Human
  • sa-mRNA vaccine Dose 1
  • +4 more
  • (no location specified)
Sep 7, 2023

Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults

Recruiting
  • Influenza
  • +2 more
  • Adjuvanted Quadrivalent Inactivated Influenza Vaccine (aIIV4)
  • High-Dose Quadrivalent Inactivated Influenza Vaccine (HD-IIV4)
  • Oakland, California
    Kaiser Permanente Northern California (entire region)
Sep 1, 2023

Vaccine Hesitancy Trial (Multilevel Intervention)

Not yet recruiting
  • Vaccine Hesitancy
  • Multilevel Intervention
  • (no location specified)
Nov 30, 2023

Safety of a Single Dose of COMVIGEN Vaccine, Reactogenicity of a Single Dose of COMVIGEN Vaccine, Immunogenicity of a Single

Not yet recruiting
  • Safety of a Single Dose of COMVIGEN Vaccine
  • +5 more
  • Comvigen (Bivalent, ChulaCov19 BNA159.2)
  • BIVALENT Pfizer/BNT vaccine
  • Bangkok, Thailand
  • +1 more
Jun 29, 2023

Influenza, Human Trial in Brisbane (ARCT-2138, Licensed Quadrivalent Vaccine for younger adults, Licensed Quadrivalent Vaccine

Not yet recruiting
  • Influenza, Human
  • ARCT-2138
  • +2 more
  • Brisbane, Queensland, Australia
    Nucleus Network Brisbane Clinic
Nov 8, 2023

Vaccine-Preventable Diseases, COVID-19 Pandemic, Health-Related Behavior Trial (Baseline surveys, Digital Storytelling

Not yet recruiting
  • Vaccine-Preventable Diseases
  • +4 more
  • Baseline surveys
  • +2 more
  • (no location specified)
Sep 12, 2023

Diphtheria, Tetanus and Acellular Pertussis Trial (Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined

Not yet recruiting
  • Diphtheria, Tetanus and Acellular Pertussis
  • Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed (DTcP)
  • +4 more
  • (no location specified)
Jul 10, 2023

Vaccine Acceptance Trial in New York (Peer-led vaccine education intervention)

Recruiting
  • Vaccine Acceptance
  • Peer-led vaccine education intervention
  • New York, New York
    NYU Grossman School of Medicine, Division of Infectious Diseases
May 16, 2023

Influenza Trial in Bangkok (TetraFluvac TF vaccine, Seasonal quadrivalent vaccine-split subunit vaccine with the strains 2023)

Not yet recruiting
  • Influenza
  • TetraFluvac TF vaccine
  • Seasonal quadrivalent vaccine-split subunit vaccine with the strains 2023
  • Bangkok, Thailand
    Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol Univ
May 30, 2023

Vaccine Hesitancy Trial in Dwarka (Happy Baby Programme -Vaccine Campaign, Happy Baby Programme- Vaccine ++ Campaign)

Not yet recruiting
  • Vaccine Hesitancy
  • Happy Baby Programme -Vaccine Campaign
  • Happy Baby Programme- Vaccine ++ Campaign
  • Dwārka, New Delhi, India
    D-COR (Development Corner) Consulting
Aug 16, 2023

Healthy Volunteers Trial in Dhaka (ShigETEC live, attenuated, oral vaccine, Placebo)

Not yet recruiting
  • Healthy Volunteers
  • ShigETEC live, attenuated, oral vaccine
  • Placebo
  • Dhaka, Bangladesh
    International Centre for Diarrhoeal Diseases Research, Banglades
Aug 3, 2023

Pneumonia, Pneumococcal, Vaccine Trial (Pneumococcal Vaccine Education)

Not yet recruiting
  • Pneumonia, Pneumococcal
  • Vaccine
  • Pneumococcal Vaccine Education
  • (no location specified)
Nov 13, 2023

SARS-CoV-2 Infection Trial in Hangzhou (Placebo, COVID-19 Vaccine (Vero Cell) ,Inactivated, COVID-19 mRNA Vaccine (ZSVG-02-O) 10

Recruiting
  • SARS-CoV-2 Infection
  • Placebo
  • +4 more
  • Hangzhou, Zhejiang, China
    Shulan (Hangzhou) Hospital
Nov 7, 2023

IsThird Dose of MMRV Vaccine Beneficial for Adult Population in

Not yet recruiting
  • Vaccination Failure
  • Vaccine Response Impaired
  • Serology for antibody levels - Baseline
  • +3 more
  • (no location specified)
Jun 26, 2023

Vaccine-Preventable Diseases, Herpes Zoster Trial in Zhenjiang (Recombinant Herpes Zoster Vaccine, Recombinant Herpes Zoster

Recruiting
  • Vaccine-Preventable Diseases
  • Herpes Zoster
  • Recombinant Herpes Zoster Vaccine
  • Recombinant Herpes Zoster Vaccine Placebo
  • Zhenjiang, Jiangsu, China
    Jiangsu Province Center for Disease Control and Prevention (Chin
Oct 12, 2023

COVID-19 Trial in Manila, Putatan (SCB-2023 vaccine (trivalent), a recombinant SARS-CoV-2 trimeric S-protein subunit vaccine for

Not yet recruiting
  • COVID-19
  • SCB-2023 vaccine (trivalent), a recombinant SARS-CoV-2 trimeric S-protein subunit vaccine for COVID-19; intramuscular injection
  • SCB-2019 (monovalent), a recombinant SARS-CoV-2 trimeric S-protein subunit vaccine for COVID-19; intramuscular injection
  • Manila, Philippines
  • +2 more
Jun 21, 2023

Hand, Foot and Mouth Disease, Herpangina Trial in Chuxiong (low dose Bivalent Enterovirus Vaccine (Vero Cell), Inactivated,

Recruiting
  • Hand, Foot and Mouth Disease
  • Herpangina
  • low dose Bivalent Enterovirus Vaccine (Vero Cell), Inactivated
  • +3 more
  • Chuxiong, Yunnan, China
    Dayao County Center for Disease Control and Prevention
Sep 25, 2023

Tumor Vaccine Benefit for Gliomas

Recruiting
  • Glioma
  • DC vaccine
  • Shanghai, China
    Huashan Hospital，Fudan University
Sep 12, 2023

Rabies Vaccine Adverse Reaction Trial in Changsha (Freeze-dried human rabies vaccine (MRC-5 cells) Zhifeilongkoma - 5-dose

Completed
  • Rabies Vaccine Adverse Reaction
  • Freeze-dried human rabies vaccine (MRC-5 cells) Zhifeilongkoma - 5-dose program
  • +3 more
  • Changsha, Hunan, China
    Hunan Provincial Center for Disease Control and Prevention
Oct 9, 2023

Aging Trial (vaccine)

Not yet recruiting
  • Aging
  • vaccine
  • (no location specified)
Nov 8, 2023